Burcon Nutrascience Corp (BU.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 50 | 32 | 22 | 12 | 6 |
| Accounts receivable | -797 | 63 | 25 | 18 | 49 |
| Accounts payable and accrued liabilities | -274 | 149 | 163 | 94 | -224 |
| Other Working Capital | -1,079 | 11 | 134 | 214 | -218 |
| Other Operating Activity | 456 | -984 | -1,033 | -557 | -402 |
| Operating Cash Flow | $-1,644 | $-730 | $-688 | $-219 | $-790 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -118 | -119 | -581 | -74 | -23 |
| Net Acquisitions | 0 | 0 | 0 | -2,000 | -3,000 |
| Purchase Sale Intangibles | -372 | -583 | -465 | -498 | -475 |
| Other Investing Activity | 0 | 6,500 | -6,500 | 0 | 0 |
| Investing Cash Flow | $-490 | $5,798 | $-7,546 | $-2,572 | $-3,498 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | 0 | 0 | 0 | 2,509 |
| Debt Issued | -10 | -3 | 59 | 0 | N/A |
| Common Stock Issued | 1,794 | 715 | 0 | 10,252 | 1 |
| Other Financing Activity | -5 | -3 | -232 | 737 | 6,812 |
| Financing Cash Flow | $1,779 | $709 | $-172 | $10,989 | $9,321 |
| Exchange Rate Effect | -2 | -1 | -1 | 2 | -1 |
| Beginning Cash Position | 12,399 | 6,623 | 15,031 | 6,831 | 1,798 |
| End Cash Position | 12,042 | 12,399 | 6,623 | 15,031 | 6,831 |
| Net Cash Flow | $-355 | $5,776 | $-8,407 | $8,198 | $5,033 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,644 | -730 | -688 | -219 | -790 |
| Capital Expenditure | -490 | -702 | -1,046 | -572 | -498 |
| Free Cash Flow | -2,133 | -1,433 | -1,734 | -791 | -1,288 |